Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Sarepta Therapeutics CEO Doug Ingram to step down amid company crossroads

27/02/2026 Published by vivi

Doug Ingram, who has led Sarepta Therapeutics for nearly a decade, announced his plans to retire by the end of... Read more

Tags: #Global Trends

Boehringer Ingelheim acquires Sitryx’s oral immunology program in deal worth over $500 million

27/02/2026 Published by vivi

On February 26, 2026, Boehringer Ingelheim secured an exclusive global license for a preclinical small-molecule inhibitor program from Sitryx Therapeutics.... Read more

Category: Uncategorized

Tags: #Global Trends

Novartis establishes fifth radiopharmaceutical plant in Texas as part of multi-billion dollar expansion

27/02/2026 Published by vivi

Novartis has unveiled plans to construct a new radioligand therapy (RLT) manufacturing facility in Denton, Texas. This project marks a... Read more

Category: Uncategorized

Tags: #Global Trends

Viatris to cut 10% of workforce amid strategic overhaul and facility setbacks in India

27/02/2026 Published by vivi

Following a year-long strategic review, Viatris announced on February 26, 2026, a plan to reduce its global workforce by approximately... Read more

Category: Uncategorized

Tags: #Global Trends

ViiV Healthcare confirms sustained efficacy of long-acting HIV injectable for adolescents

27/02/2026 Published by vivi

At the 33rd Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented 96-week data from the Mocha study (IMPAACT... Read more

Category: Uncategorized

Tags: #Global Trends

FDA grants speedy first-line expansion for Boehringer’s Hernexeos in NSCLC treatment

27/02/2026 Published by vivi

On February 26, 2026, the FDA granted expanded approval for Boehringer Ingelheim’s Hernexeos (zongertinib) as a first-line treatment for patients... Read more

Category: Uncategorized

Tags: #Global Trends

Cancer treatments lead the proposal for expansion of Health Insurance coverage

27/02/2026 Published by vivi

The Health Insurance Department under the Ministry of Health is developing a proposal to add 84 new chemical and biological... Read more

Category: Uncategorized

Tags: #Vietnam

FDA grants full approval to Pfizer’s combination therapy for first-line metastatic colorectal cancer

26/02/2026 Published by vivi

On February 25, 2026, the U.S. Food and Drug Administration (FDA) issued full approval for Pfizer’s Braftovi (encorafenib) in combination... Read more

Category: Uncategorized

Tags: #Global Trends